Contributors
James L. Abbruzzese(Duke University), Robert E. Coleman, Megan E. Anderson, Juliet L. Aylward, Jeff Boyd(Northwell Health), Therese B. Bevers(The University of Texas MD Anderson Cancer Center), Shaheen Alanee, Julie R. Brahmer(Johns Hopkins University), Emmanuel S. Antonarakis(University of Minnesota), Steven R. Alberts(North Central Cancer Treatment Group), Michelle Alonso‐Basanta(University of Pennsylvania), Paul M. Cinciripini(The University of Texas MD Anderson Cancer Center), Jorge J. Castillo(Dana-Farber Cancer Institute), Al B. Benson(Northwestern University), H. Ballentine Carter, Nai‐Kong V. Cheung(Memorial Sloan Kettering Cancer Center), John F. Boggess(University of Kentucky), Vikash P. Chauhan(Massachusetts Institute of Technology), Anthony J. Cmelak(Breast Cancer Research Foundation), Joanna M. Brell(Ontario Institute for Cancer Research), Herbert Chen(University of Alabama at Birmingham), Richard E. Champlin(The University of Texas MD Anderson Cancer Center), Dara L. Aisner(University of Colorado System), Frederick R. Appelbaum(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Ali A. Baaj, Karen Brown(University of Leicester), Jeffrey S. Abrams(National Cancer Institute), David P. Carbone(Vanderbilt University), Janet L. Abrahm(Harvard University), Dario Campana(National University of Singapore), Qaiser Bashir(The University of Texas MD Anderson Cancer Center), Powel H. Brown(The University of Texas MD Anderson Cancer Center), Arjun Vasant Balar(NYU Langone Health), Paul A. Bunn(University of Colorado Denver), Lodovico Balducci(Moffitt Cancer Center), Donald A. Berry(Berry & Associates (United States)), Nancy L. Bartlett(Washington University in St. Louis), Ronald C. Chen(University of North Carolina at Chapel Hill), Leif‐Erik Bohman, Ghassan K. Abou‐Alfa(Memorial Sloan Kettering Cancer Center), Ross S. Berkowitz(Dana-Farber Brigham Cancer Center), Michael F. Clarke(La Trobe University), Jonathan B. Ashman(Mayo Clinic in Arizona), Stephen J. Chanock(National Cancer Institute), Alfred E. Chang(University of Michigan), Michael J. Borowitz(Johns Hopkins University), Manpreet Chadha, John C. Byrd(University of Cincinnati), Michaele C. Christian(Walter Reed Army Institute of Research), Lynda K. Beaupin(Roswell Park Comprehensive Cancer Center)
Cited by 0
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k